Objectives. To examine racial/ethnic disparities in Hawaii in stage 3 classification at HIV diagnosis and trends in such disparities from 2010 through 2016.
L ate-stage HIV diagnoses are detrimental for both individual and population health. Patients diagnosed late may not reap the full benefits of an early diagnosis and treatment and consequently suffer from increased morbidity and mortality. [1] [2] [3] [4] In addition, patients diagnosed with late-stage HIV infection often have been living with the virus for years, may have been unaware of their status, and may have unknowingly transmitted the virus to others. [5] [6] [7] [8] According to the most recent data from the Centers for Disease Control and Prevention (CDC), about 1 in 5 (21.6%) HIV infections diagnosed in 2015 in the United States were classified as stage 3 (AIDS) at the time of diagnosis. 9 The overall percentage of such diagnoses decreased from 2010 to 2015, and declines were seen in all racial/ethnic groups. 9 An examination of data for 2015 alone shows that percentages of infections classified as stage 3 were highest among American Indians/Alaska Natives (24.4%), individuals of multiple races (23.9%), and Hispanics/ Latinos (22.7%). However, an analysis of data across 2010 through 2015 indicates that percentages were highest among Native Hawaiians and other Pacific Islanders (NHPIs) from 2010 through 2013 (51.0%, 40.0%, 31.5%, and 34.0% respectively) before decreasing in 2014 (23.3%) and 2015 (20.5%). 9 As a result of small numbers of NHPI cases nationally, the 2014 and 2015 findings may reflect random fluctuations rather than true declines in late-stage diagnoses.
Historically, Asians and Pacific Islanders have been reported as more likely than members of other racial groups to receive a late-stage HIV diagnosis and to have an opportunistic infection at the time of diagnosis. 10, 11 Also, they have been found to have lower CD4+ cell counts at initiation of treatment, lower rates of treatment adherence, and poorer survival rates than do Whites. [12] [13] [14] [15] Asians, NHPIs, and individuals of mixed races constituted two thirds (67%) of Hawaii's population in 2010. 22 Those populations have often been understudied nationally. A recent CDC publication on social determinants of stage 3 HIV diagnoses combined Asians, NHPIs, American Indians/Alaska Natives, and individuals of multiple races into an "other" category. 23 Our objective in the study described here was to examine disparities in Hawaii in stage 3 classification at HIV diagnosis and trends in such disparities across the 7-year period spanning 2010 through 2016. Given the unique racial/ethnic composition and distribution of Hawaii's population, we hypothesized that Asians and NHPIs were more likely to receive a stage 3 diagnosis than were Whites after adjustment for other individual and social determinants.
METHODS
The data used in our study included 
Predictor Variables
A number of variables were assessed for their associations with late-stage HIV diagnosis, including sex at birth (male or female) and age (in years) at HIV diagnosis HIV transmission categories (by group) were defined as follows: male-to-male sexual contact, male injection drug use, female injection drug use, male-to-male sexual contact and injection drug use in combination, male heterosexual contact, female heterosexual contact, and "other" (risk factors not identified or reported). The male-to-male sexual contact category included men who had ever had sexual contact with other men (i.e., homosexual contact) and men who had ever had sexual contact with both men and women (i.e., bisexual contact). The heterosexual contact group included individuals who had ever had heterosexual contact with a person known to have or to be at high risk for HIV infection (e.g., an injection drug user).
We also assessed year of HIV diagnosis (based on the year of the diagnosis date) and county of residence at diagnosis. The state of Hawaii consists of 8 major islands organized into 5 counties: Honolulu County (Oahu island), Hawaii County (Hawaii island), Maui County (Molokai, Lanai, Maui, and Kahoolawe islands), Kauai County (Kauai and Niihau islands), and Kalawao County. Kalawao County, the former Hansen's disease colony, was excluded from further analysis because there were no HIV cases there. Honolulu County houses the state's capital and is highly urbanized and developed. The other 3 counties consist of neighboring islands and have larger proportions of NHPIs, higher levels of poverty, and larger proportions of people without health insurance than does Honolulu County. 27 We classified the types of facilities where HIV was diagnosed as (1) inpatient facilities or hospitals where services are provided to patients who stay overnight while they undergo treatment, examination, or observation; (2) outpatient facilities where patients receive services but do not stay overnight (emergency room visits were included in this category); or (3) other types of facilities. The latter category included social service facilities, agencies, and organizations that provide assistance (e.g., emotional, financial, medical) to HIV-infected individuals or provide HIV and sexually transmitted disease counseling, testing, and medical treatment referral services but do not offer ongoing HIV-related medical care, social services, or other health services.
Finally, location of birth was categorized as follows: United States, Asian countries, Pacific countries or locations, and other locations. Pacific countries and locations included the US Affiliated Pacific Islands (American Samoa, Guam, the Commonwealth of the Northern Mariana Islands, and FAS), the Kingdom of Tonga, and the Independent State of Samoa.
Statistical Analysis
Rates (per 100 000 population) of diagnosed HIV infection (all stages) and rates of late-stage (AIDS) diagnosis were calculated by year and evaluated according to the c 2 trend test. We present descriptive statistics on the characteristics of the study population. Stage of disease at the time of HIV diagnosis was estimated overall and stratified by patient's sex at birth, age, race/ethnicity, transmission category, county of residence at diagnosis, type of diagnosing facility, and other factors of interest. We conducted the c 2 test to compare proportions of late-stage (AIDS) diagnoses between groups. The Fisher exact test was used for small-sample comparisons.
Logistic regression models were used to assess the relationship of late-stage (AIDS) diagnosis with race/ethnicity after adjustment for sex at birth, age, residential county at HIV diagnosis, transmission category, and other factors of interest. Odds ratios (OR) and 95% confidence intervals (CIs) were the primary statistics reported via the models. We used SAS version 9.4 (SAS Institute Inc, Cary, NC) in conducting all of our statistical analyses. Relative to Hawaii's 2010 census data, 22 HIV infections were overrepresented among male patients (88.9% vs 50.1% reported in the census) and among individuals 25 to 34 years (33.7% vs 13.6%), 35 to 44 years (22.3% vs 13.0%), and 45 to 54 years (20.8% vs 14.3%) years of age. Whites (33.6% vs 22.8%), Blacks (8.0% vs 1.5%), and NHPIs (14.7% vs 9.5%) were also overrepresented, whereas Asians (21.5% vs 37.9%) and individuals of multiple races (12.8% vs 19.2%) were underrepresented.
RESULTS
Male-to-male sexual contact was the dominant transmission risk factor (66.7%), followed by male heterosexual contact (8.6%). Infections as a result of risk factors not reported or not identified constituted 7.3% of all infections. Nearly three quarters The vast majority of patients had been born in the United States (85.6%), whereas approximately 10% had been born in Asian countries (9.9%). A total of 7 individuals (1.2%) were from the Pacific, and the remaining 3.3% were born in other locations. About three quarters (70.9%) of HIV infections were diagnosed in outpatient facilities, 16.8% in inpatient facilities, and 12.3% in other types of facilities. The percentage of late-stage diagnoses did not differ significantly according to patient's sex at birth (P = .73), residential county at diagnosis (P = .12), or birth country (P = .86).
Rates of Diagnosed HIV Infections and Late-Stage Diagnoses
The percentage of late-stage diagnoses differed significantly according to patient age (P < .001), race/ethnicity (P < .001), transmission risk factors (P = .003), and type of diagnosis facility (trend P < .001). The percentage of late-stage diagnoses increased as age increased; for example, the percentages were 8.9% among those 13 to 24 years old and 46.1% among those 55 years old or older. With respect to race/ethnicity, the percentages of late-stage diagnoses were highest among NHPIs (47.5%) and Asians (35.9%). When examined according to transmission categories, the percentage of late-stage diagnoses was highest in the male injection drug use group (59.4%), followed by the male heterosexual contact group (37.9%). The percentage was much higher in inpatient facilities (61.1%) than in outpatient facilities (25.3%) or other types of community service facilities (8.9%).
Logistic Regression Findings
The model assessing the relationship of late-stage diagnosis with race/ethnicity while simultaneously adjusting for all other predictors showed that the association remained significant after these adjustments (P = .006; Table 3 ). Relative to Whites, the odds of being diagnosed at stage 3 were more than 3 times higher among NHPIs (OR = 3.69; 95% CI = 1.89, 7.22) and more than twice as high among Asians (OR = 2.46; 95% CI = 1.16, 5.20). Other variables remaining significant included age at diagnosis (P < .001) and type of diagnosis facility (P < .001). Patients 35 to 44 years old (OR = 7.1; 95% CI = 2.55, 19.74), 45 to 54 years old (OR = 11.08; 95% CI = 3.97, 30.96), and 55 years old or older (OR = 11.78; 95% CI = 3.84, 36.11) were much more likely than patients 13 to 24 years to be diagnosed at stage 3.
The odds of late-stage diagnoses were 5.3 times higher among those diagnosed at inpatient facilities (OR = 5.26; 95% CI = 2.94, 9.43) than among those diagnosed at outpatient facilities. By contrast, the odds of being diagnosed at stage 3 were 75% lower among patients diagnosed at community service facilities (OR = 0.25; 95% CI = 0.10, 0.63) than among those diagnosed at outpatient facilities.
Year of diagnosis was not significant in the multivariable logistic regression analysis. In addition, no significant associations were found between stage 3 diagnoses and patients' sex at birth, county of residence at HIV diagnosis, birth country, or transmission category.
DISCUSSION
Using 2010 to 2016 population-based statewide surveillance data from Hawaii, we found that about 30% of all HIV diagnoses were classified as late-stage diagnoses, a percentage higher than the national 2010 to 2015 average of 25.9%. 9 The proportion of late-stage HIV diagnoses was higher in Hawaii than the national average from 2010 to 2014; in 2015, Hawaii's proportion decreased to a level similar to the national average. 9 We observed significant racial/ethnic disparities in late-stage HIV diagnoses across the 7-year study period. Relative to Whites, the odds of being diagnosed at stage 3 were 3.7 times higher among NHPIs and 2.5 times higher among Asians after adjustment for other potential predictors of late diagnosis. It is noteworthy that year of diagnosis and transmission category were not significant in our multivariable logistic regression models. Such findings indicate that any differences observed in late-stage HIV diagnoses during the 7-year study period were actually driven by race/ ethnicity rather than by year of diagnosis or behavioral risk factors. In the case of all risk categories, the racial/ethnic disparities existed each year during the 7-year study period. Despite enhanced advocacy and availability of HIV testing and screening over the past decade, disparities in late-stage HIV diagnoses among Asians and NHPIs did not improve. 10, 11, 16, 17 Other significant predictors of late-stage diagnoses included type of diagnosis facility and age at diagnosis, findings largely consistent with those of other studies. Several other studies have shown that late diagnoses are more common among older adults and among patients diagnosed in hospitals. late-stage HIV diagnosis. 21, 23 In our study, patients born in other locations, including Asian countries, were less likely to be diagnosed at stage 3, although this finding was not statistically significant. By contrast, patients born in the US Affiliated Pacific Islands and Pacific countries in which NHPIs were the dominant racial group were 4 times more likely to be diagnosed late than were those born in the United States. Again, however, this finding was not significant, most likely as a result of the group's small sample size.
In 2015, an estimated 20% of Asians and 18% of NHPIs who were living with HIV were undiagnosed, compared with a national average of 14.5%. 30, 31 Recent studies have shown that young adult Asians and NHPIs are more likely than members of other racial/ ethnic groups to engage in oral and anal sex without a condom but less likely to have a history of testing and counseling for sexually transmitted infections, including HIV testing. 16 Although the prevalence of HIV is low among Asians and NHPIs relative to other racial/ethnic groups, they exhibit the highest estimated annual percentage increases in rates of HIV diagnosis. 9 Future studies linking surveillance data with HIV testing data would allow examinations of whether Asians and NHPIs are less likely to be tested in Hawaii and whether positivity rates among these groups are lower than those among Whites. Studies that examine both cultural strengths and cultural barriers in the continuum of HIV care, starting from HIV testing and counseling, are most needed. The findings of such investigations would shed light on our understanding of HIV testing behaviors in these 2 populations and facilitate the development of more targeted, effective interventions and preventive services. 16, 17 CONTRIBUTORS F. Li led the study design and concept, completed the statistical analysis, the writing of the article, and the interpretation of the data. B. K. Juan, M. Wozniak, and S. K. Watson led the study design and concept, led the interpretation of the data, and critically reviewed the article. A. R. Katz, P. M. Whiticar, T. McCormick, Y. S. Qiu, and G. M. Wasserman participated in the study design and concept, contributed to the interpretation of the data, and critically reviewed the article.
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